BioChemics, Inc. Awarded Patent for Development of Bifunctional Synthetic Molecules – A Novel Drug Delivery And Efficacy Enhancement Technology
1/30/2013 9:41:45 AM
DANVERS, Mass.--(BUSINESS WIRE)--BioChemics announced today that it has received a patent for a new breakthrough drug delivery technology. This technology called Bifunctional Synthetic Molecule, or BSM, involves covalently bonding two existing different molecules together to create a unique, new and chemically-stable molecule which contains desired physicochemical properties for the purpose of enhanced dermal, or other tissue, penetration. BSM also provides co-localization of the different components of the new molecule in the target tissue at the same time, further enhancing efficacy of the drug.